SpringerProtocols: Abstract: 22. Humanized Mouse Models to Study the Human Haematopoietic Stem Cell Compartment

22. Humanized Mouse Models to Study the Human Haematopoietic Stem Cell Compartment

By: Dominique Bonnet³

Abstract

Full Text

Download PDF (390K)

The ideal way to assess hematopoietic stem cells is to observe their growth in the endogenous microen-vironment where they would receive the appropriate signals. With colonies of inbred mice, it is possible to myeloablate recipients and transplant hematopoietic cells from genetically similar mice and observe the growth of primitive hematopoietic cells in their endogenous environment for a significant proportion (10 months) of an organisms lifespan (29 months average). It is not possible to perform these experiments in humans, but xenotransplantation mouse models provide the closest paradigm for the human hematopoietic environment at the present time.

Affiliation(s): (3) Haematopoietic Stem Cell Laboratory, Cancer Research UK, London Research Institute, London, UK

Book Title: Genetic Modification of Hematopoietic Stem Cells: Methods and Protocols

Series: Methods in Molecular Biology | Volume: 506 | Pub. Date: Jul-01-2008 | Page Range: 331-340 | DOI: 10.1007/978-1-59745-409-4_22

Subject: Cell Biology

Key Words: Hematopoietic stem cell - Xenotransplantation - Immunodeficient mice

References

Download References

1.	Zanjani, E. D. (1997). The human/sheep xenograft model for assay of human HSC (discussion). Stem Cells 15 Suppl 1, 209.

2.	Zanjani, E. D., Flake, A. W., Almeida- Porada, G., Tran, N., and Papayannopoulou, T. (1999). Homing of human cells in the fetal sheep model: modulation by antibodies activating or inhibiting very late activation antigen-4-dependent function. Blood 94, 2515–2522.

3.	Almeida-Porada, G., Porada, C., and Zanjani, E. D. (2001). Adult stem cell plasticity and methods of detection. Rev Clin Exp Hematol 5, 26–41.

4.	Lapidot, T., Pflumio, F., Doedens, M., Murdoch, B., Williams, D. E., and Dick, J. E. (1992). Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255, 1137–1141.

5.	Vormoor, J., Lapidot, T., Pflumio, F., Risdon, G., Patterson, B., Broxmeyer, H. E., et al. (1994). Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 83, 2489–2497.

6.	Cashman, J. D., Lapidot, T., Wang, J. C., Doedens, M., Shultz, L. D., Lansdorp, P., et al. (1997). Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood 89, 4307–4316.

7.	Larochelle, A., Vormoor, J., Hanenberg, H., Wang, J. C., Bhatia, M., Lapidot, T., et al. (1996). Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med 2, 1329–1337.

8.	Shultz, L. D., Schweitzer, P. A., Christianson, S. W., Gott, B., Schweitzer, I. B., Tennent, B., et al. (1995). Multiple defects in innate and adaptive immunologic function in NOD/ LtSz-scid mice. J Immunol 154, 180–191.

9.	Dick, J. E. (1996). Normal and leukemic human stem cells assayed in SCID mice. Semin Immunol 8, 197–206.

10.	Hogan, C. J., Shpall, E. J., McNiece, I., and Keller, G. (1997). Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34 + peripheral blood progenitor cells. Biol Blood Marrow Transplant 3, 236–246.

11.	Matsuzaki, Y., Kinjo, K., Mulligan, R. C., and Okano, H. (2004). Unexpectedly efficient homing capacity of purified murine hemat-opoietic stem cells. Immunity 20, 87–93.

12.	Yahata, T., Ando, K., Sato, T., Miyatake, H., Nakamura, Y., Muguruma, Y., et al. (2003). A highly sensitive strategy for SCID-repopu-lating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood 101, 2905–2913.

13.	Guenechea, G., Gan, O. I., Dorrell, C., and Dick, J. E. (2001). Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat Immunol 2, 75–82.

14.	Christianson, S. W., Greiner, D. L., Hesselton, R. A., Leif, J. H., Wagar, E. J., Schweitzer, I. B., et al. (1997). Enhanced human CD4 + T cell engraftment in beta2-microglobulin-deficient NOD-scid mice. J Immunol 158, 3578–3586.

15.	Glimm, H., Eisterer, W., Lee, K., Cashman, J., Holyoake, T. L., Nicolini, F., et al. (2001). Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice. J Clin Invest 107, 199–206.

16.	Kollet, O., Peled, A., Byk, T., Ben-Hur, H., Greiner, D., Shultz, L., et al. (2000). beta2 microglobulin-deficient (B2m(null)) NOD/ SCID mice are excellent recipients for studying human stem cell function. Blood 95, 3102–3105.

17.	Hiramatsu, H., Nishikomori, R., Heike, T., Ito, M., Kobayashi, K., Katamura, K., et al. (2003). Complete reconstitution of human lymphocytes from cord blood CD34 + cells using the NOD/SCID/gammacnull mice model. Blood 102, 873–880.

18.	Yahata, T., Ando, K., Nakamura, Y., Ueyama, Y., Shimamura, K., Tamaoki, N., et al. (2002). Functional human T lymphocyte development from cord blood CD34 + cells in nonobese diabetic/Shi-scid, IL-2 receptor gamma null mice. J Immunol 169, 204–209.

19.	Ishikawa, F., Yasukawa, M., Lyons, B., Yosh-ida, S., Miyamoto, T., Yoshimoto, G., et al. (2005). Development of functional human blood and immune systems in NOD/SCID/ IL2 receptor {gamma} chain(null) mice. Blood 106, 1565–1573.

20.	Shultz, L. D., Lyons, B. L., Burzenski, L. M., Gott, B., Chen, X., Chaleff, S., et al. (2005). Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174, 6477–6489.

21.	Traggiai, E., Chicha, L., Mazzucchelli, L., Bronz, L., Piffaretti, J. C., Lanzavecchia, A., et al. (2004). Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304, 104–107.

22.	Shultz, L. D., Ishikawa, F., and Greiner, D. L. (2007). Humanized mice in translational biomedical research. Nat Rev Immunol 7, 118–130.

23.	Cashman, J. D., and Eaves, C. J. (2000). High marrow seeding efficiency of human lym-phomyeloid repopulating cells in irradiated NOD/SCID mice. Blood 96, 3979–3981.

24.	van der Loo, J. C., and Ploemacher, R. E. (1995). Marrow- and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors. Blood 85, 2598–2606.

25.	Mazurier, F., Doedens, M., Gan, O. I., and Dick, J. E. (2003). Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat Med 9, 959–963.

26.	Wang, J., Kimura, T., Asada, R., Harada, S., Yokota, S., Kawamoto, Y., et al. (2003). SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection. Blood 101, 2924–2931.

27.	Shultz, L. D., Banuelos, S. J., Leif, J., Appel, M. C., Cunningham, M., Ballen, K., et al. (2003). Regulation of human short-term repopulating cell (STRC) engraftment in NOD/SCID mice by host CD122 + cells. Exp Hematol 31, 551–558.

28.	Verlinden, S. F., van Es, H. H., and van Bekkum, D. W. (1998). Serial bone marrow sampling for long-term follow up of human hematopoiesis in NOD/SCID mice. Exp Hematol 26, 627–630.

Comments (Loading...)

Post comment/View all comments